Reactions Weekly

, Volume 1694, Issue 1, pp 157–157 | Cite as

Dasatinib

Various toxicites
Case report
  • 13 Downloads

Reference

  1. Kampa-Schittenhelm KM, et al. Dasatinib overrides the differentiation blockage in a patient with mutant-KIT D816V positive CBFbeta-MYH11 leukemia. Oncotarget 9: 11876-11882, No. 14, 20 Feb 2018. Available from: URL: http://doi.org/10.18632/oncotarget.24376 - Germany

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations